Notably, the Toll-like receptor signaling pathway and NF-κB signaling pathway have been previously proven to play crucial roles in the pathogenesis of AD by regulating microglia-derived proinflammatory responses (Jha et al., 2019; Su et al., 2016). The gene discussed is NFKB1; the disease is Alzheimer disease.